Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 13, 2021

SELL
$15.71 - $21.51 $31,420 - $43,020
-2,000 Reduced 40.0%
3,000 $65,000
Q3 2019

Oct 03, 2019

BUY
$12.27 - $15.79 $61,350 - $78,950
5,000 New
5,000 $66,000
Q2 2019

Jul 15, 2019

SELL
$13.37 - $18.85 $66,850 - $94,250
-5,000 Closed
0 $0
Q3 2017

Oct 06, 2017

BUY
$15.4 - $18.85 $77,000 - $94,250
5,000
5,000 $90,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $273M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.